NovoCure Limited (NVCR) Net margin 2017–2026
NovoCure Limited (NVCR) net profit margin by fiscal year — reported net income divided by reported revenue.
-20.8%FY2026 · since FY2017: -159.1% → -20.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -20.8% | +7.1 pp |
| FY2025 | -27.9% | +12.8 pp |
| FY2024 | -40.6% | -23.4 pp |
| FY2023 | -17.2% | -6.3 pp |
| FY2022 | -10.9% | -14.9 pp |
| FY2021 | 4.0% | +6.1 pp |
| FY2020 | -2.1% | +23.6 pp |
| FY2019 | -25.6% | +9.2 pp |
| FY2018 | -34.8% | +124.2 pp |
| FY2017 | -159.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NVCR financial trends
NVCR RevenueNVCR Net incomeNVCR Gross profitNVCR Gross marginNVCR Operating incomeNVCR Operating marginNVCR Operating cash flowNVCR Free cash flowNVCR Capital expendituresNVCR Return on equityNVCR Stock buybacksNVCR Dividends paidNVCR Total assetsNVCR Total liabilitiesNVCR Shareholders’ equityNVCR overview →